Garry Neil
2021
In 2021, Garry Neil earned a total compensation of $1.2M as Chief Executive Officer, President, Chairman of the Board and principal executive officer at Avalo Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $239,587 |
---|---|
Option Awards | $571,484 |
Salary | $423,000 |
Total | $1,234,071 |
Neil received $571.5K in option awards, accounting for 46% of the total pay in 2021.
Neil also received $239.6K in non-equity incentive plan and $423K in salary.
Rankings
In 2021, Garry Neil's compensation ranked 8,018th out of 12,415 executives tracked by ExecPay. In other words, Neil earned more than 35.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,018 | 35th |
Manufacturing | 3,549 | 36th |
Chemicals And Allied Products | 1,578 | 34th |
Drugs | 1,403 | 33rd |
Pharmaceutical Preparations | 1,041 | 33rd |
Neil's colleagues
We found four more compensation records of executives who worked with Garry Neil at Avalo Therapeutics in 2021.